Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug 15;179(4):2318-29.
doi: 10.4049/jimmunol.179.4.2318.

Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3

Affiliations

Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3

Cuong Q Nguyen et al. J Immunol. .

Abstract

The role of complement in the etiology of Sjögren's syndrome (SjS), a human autoimmune disease manifested primarily by salivary and lacrimal gland dysfunction resulting in dry mouth/dry eye syndrome, remains ill-defined. In the present study, we examined the role of complement component-3 (C3) using a newly constructed C3-gene knockout mouse, C57BL/6.NOD-Aec1Aec2.C3(-/-). Inactivation of C3 in the parental C57BL/6.NOD-Aec1Aec2 strain, a model of primary SjS, resulted in a diminished or total absence of both preclinical and clinical manifestations during development and onset of disease, including reduced acinar cell apoptosis, reduced levels of caspase-3, lack of leukocyte infiltration of submandibular glands, reduced synthesis of disease-associated autoantibodies, maintenance of normal glandular architecture, and retention of normal saliva secretion. In addition, C57BL/6-NOD.Aec1Aec2.C3(-/-) mice did not exhibit increased numbers of marginal zone B cells, a feature of SjS-prone C57BL/6-NOD.Aec1Aec2 mice. Interestingly, C57BL/6-NOD.Aec1Aec2.C3(-/-) mice retained some early pathological manifestations, including activation of serine kinases with proteolytic activity for parotid secretory protein. This improvement in the clinical manifestations of SjS-like disease in C57BL/6.NOD-Aec1Aec2.C3(-/-) mice, apparently a direct consequence of C3 deficiency, supports a much more important role for complement in the adaptive autoimmune response than previously recognized, possibly implicating an essential role for innate immunity.

PubMed Disclaimer

Conflict of interest statement

Disclosures The authors have no financial conflict of interest.

Figures

FIGURE 1
FIGURE 1
Detection of aberrant serine proteolytic activity in saliva of C57BL/6.NOD-Aec1Aec2 and C57BL/6.NOD-Aec1Aec2.C3−/− mice, but not C57BL/6 mice. Saliva collected from individual animals between the ages of 4 and 24 wk were incubated with the synthetic oligopeptide EAVPQNLN LDVELLQQ representing a sequence from the N terminus of PSP with the NLNL proteolytic site for activated serine kinases. Following 2-h incubation at 42°C, each reaction was diluted with Tris-HCl, centrifuged through Microspin filter tubes, and the filtrates were separated by HPLC. Synthesized PSP oligopeptide, whether analyzed in buffer (A) or in the presence of control C57BL/6 saliva (B) reproducibly elutes at 13.8 min (A). PSP oligopeptide, when incubated with saliva from C57BL/6.NOD-Aec1Aec2 mice known to be predisposed to develop SjS-like disease and to contain activated serine kinases, is digested to produce the two cleaved fragments that elute at ~9.0 and 12.5 min (C). Proteolysis of the synthetic PSP oligopeptide was observed when incubated in saliva from C57BL/6.NOD-Aec1Aec2.C3−/− mice (D). Although saliva from each mouse in each of the three groups were tested for enzyme activity, the data presented depict a single, representative HPLC run from each group.
FIGURE 2
FIGURE 2
Temporal changes in levels of apoptosis in submandibular glands of C57BL/6.NOD-Aec1Aec2 and C57BL/6.NOD-Aec1Aec2.C3−/− mice using cleaved caspase-3 by immunohistochemistry. A, Detection of cleaved products of caspase-3 on histological sections of submandibular glands from C57BL/6 mice at 4 (a) and 27 (b) wk of age, C57BL/6.NOD-Aec1Aec2 mice at 4 (c) and 27 (d) wk of age, and C57BL/6.NOD-Aec1Aec2.C3−/− mice at 4 (e) and 27 (f) wk of age (n = 4 mice in each group and at each time point). B, Quantification of apoptotic events observed in the submandibular glands of C57BL/6 (black fill), C57BL/6.NOD-Aec1Aec2 (stippled fill), and C57BL/6.NOD-Aec1Aec2.C3−/− (clear fill) mice during the early (4–7 wk of age) vs late (24–27 wk of age) stages of disease. Statistical differences were analyzed by the Student-Newman-Keuls test using GraphPad InStat3. ***, p < 0.001; NS, not statistically significant.
FIGURE 3
FIGURE 3
Histological examination of submandibular glands C57BL/6, C57BL/6.NOD-Aec1Aec2, and C57BL/6.NOD-Aec1Aec2.C3−/− mice at various ages. Submandibular glands were removed at time of euthanization from mice within each group, fixed in 10% formalin, embedded in paraffin, and cut for 5-μm thickness serial sections. Each section was stained with Mayer’s H&E dye (A–C, E–G, and I–K) to identify the presence or absence of leukocytic foci. Foci were present only in the glands C57BL/6.NOD-Aec1Aec2 mice before 30 wk of age (as depicted in F). After 30 wk, infiltrates were observed in all three strains (C, G, and K). Immunohistological staining for CD3+ T (green) and B220 B (red) cells showed the presence of each cell populations within the infiltrates (D, H, and L). Nuclei were stained with DAPI (blue).
FIGURE 4
FIGURE 4
Identification of MZ vs FO B cell populations in the spleens of female and male C57BL/6, C57BL/6.NOD-Aec1Aec2, and C57BL/6.NOD-Aec1Aec2.C3−/− mice. Single-cell suspensions of splenic leukocytes from 24-wk-old C57BL/6 (n = 3, left panels), 26-wk-old C57BL/6.NOD-Aec1Aec2 (n = 3, middle panels), or 27-wk-old C57BL/6.NOD-Aec1Aec2.C3−/− (n = 4, right panels) female and male mice were incubated with FITC-conjugated rat anti-mouse CD21 mAb and R-PE-conjugated rat anti-mouse CD23, then analyzed by flow cytometry for differential fluorescence intensity based on CD21 and CD23 markers to identify MZ (CD21highCD23int), and FO (CD21intCD23low) B cells. Data presented in A and B are representative flow cytometric analysis of MZ and FO B cells in individual mice, while the cumulative data from each experimental group of female and male mice are presented in C and D, respectively. Data presented are the means ± SE. Statistical differences were analyzed with the Student-Newman-Keuls test using GraphPad InStat3. **, p < 0.01; ***, p < 0.001.
FIGURE 5
FIGURE 5
Identification of the autoantibodies patterns in sera of C57BL/6, C57BL/6.NOD-Aec1Aec2, and C57BL/6.NOD-Aec1Aec2.C3−/− mice. A, Representative patterns of cellular staining of Hep2 cells by sera prepared from C57BL/6.NOD-Aec1Aec2 (n = 33), C57BL/6.NOD-Aec1Aec2.C3−/− (n = 24), and C57BL/6 (n = 11) mice. Fixed HEp-2 substrate slides were incubated with individual mouse sera diluted 1/40, followed by development with FITC-conjugated goat anti-mouse IgG. Fluorescent patterns were detected by fluorescence microscopy at ×200 magnification. B, Percentage of individual mouse sera exhibiting the specific patterns of staining. Statistical analysis was performed using χ2 test. ***, p < 0.001.
FIGURE 6
FIGURE 6
Detection of anti-M3R Abs. Pooled sera collected from C57BL/6 (27 wk of age), C57BL/6.NOD-Aec1Aec2 (30 wk of age), and C57BL/6.NOD-Aec1Aec2.C3−/− (24 wk of age) mice. Mouse M3R-transfected Flp-In CHO cells were incubated with either a pooled sera or respective isotype control sera. Cells were washed with FACS buffer, resuspended in 50 μl of FACS buffer and developed with either FITC-conjugated goat anti-mouse IgM, IgG1, IgG2b, IgG2c, or IgG3, then analyzed using a FACScan cytometer. M (marker) values equal mean fluorescent indices.
FIGURE 7
FIGURE 7
Temporal changes in stimulated saliva flow rates of C57BL/6, C57BL/6.NOD-Aec1Aec2, and C57BL/6.NOD-Aec1Aec2.C3−/− female (A) and male (B) mice. Stimulated saliva flow rates are presented for sets of mice selected within each experimental group following injections of isopreterenol/pilocarpine solution at the times indicated in the figures. Saliva was collected for 10 min from the oral cavity using a micropipette starting 1 min after injection of the secretagogue. The volumes of individual collections were determined and the mean of collections within each group determined. **, p < 0.01; ***, p < 0.001.

Similar articles

Cited by

References

    1. Fox RI, Kang HI. Pathogenesis of Sjögren’s syndrome. Rheum Dis Clin North Am. 1992;18:517–538. - PubMed
    1. Jonsson R, Haga HJ, Gordon TP. Current concepts on diagnosis, autoantibodies and therapy in Sjögren’s syndrome. Scand J Rheumatol. 2000;29:341–348. - PubMed
    1. Fox RI, Michelson P. Approaches to the treatment of Sjögren’s syndrome. J Rheumatol Suppl. 2000;61:15–21. - PubMed
    1. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–558. - PMC - PubMed
    1. Fox PC, Speight PM. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren’s syndrome. Crit Rev Oral Biol Med. 1996;7:144–158. - PubMed

Publication types

MeSH terms